The rising global incidences of cancer and tumorigenesis, increasing demand for personalized medicine and various training programs to raise the awareness by the government are expected to be some primary market drivers.
According to the current analysis of Reports and Data, the Anatomic Pathology market was valued at USD 34.38 billion in 2020 and is expected to reach USD 56.22 billion by the year 2028, at a CAGR of 6.3%. The Anatomic pathology is a branch of medicine that deals with the diagnosis and effect of diseases on the body. The process relies on direct visualization of organ tissues, both grossly and microscopically. Various stains are used to identify and classify different microorganisms for disease diagnosis. The rising prevalence of cancer and tumorigenesis is expected to drive the industry widely. Diagnosis of cancer in anatomic pathology using biomarkers is a growing trend in the market. According to the World Health Organization, nearly 9.6 million deaths in 2018 occurred due to cancer; Cancer is the second leading cause of death globally. About 1 in 6 deaths is due to cancer. These deaths could have been avoided with the availability of proper medical equipment and devices for healthcare procedures. This significant number is expected to act as a driver to market growth. The increasing cases of targeted diseases due to unknown new organisms is also expected to propel the market growth. These diseases affect different people with different types and need treatment accordingly. Therefore, the rising demand for personalized medicines may fuel the market in the future. Mergers and acquisitions among various industry players to increase their profits could also propel the market growth in the forecast period. Furthermore, to increase awareness about anatomic pathology among healthcare professionals, the government is taking initiatives and has introduced various training modules to ensure proper training to the trainees. Regionally, developing countries such as India and China has enormous untapped potential providing a favorable growth scenario. The favorable reimbursement policies and technological advancements in the region will further boost the market growth.
Key companies profiled in the report include
Sakura Finetek, F. Hoffmann-La Roche Ltd., BioGenex Laboratories, Thermo Fisher Scientific, Hologic, Inc., Becton, Dickinson and Company, Agilent Technologies, Merck KGaA, Bio SB, Diapath S.p.A., and Danaher Corporation.
Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/2763
The report is an investigative study that determines market growth and market scope on the basis of market trends, consumer behavior shifts, consumption and production patterns, product portfolio offered by the market, growth rate, drivers and constraints, financial positions, and existing challenges and limitations of the Anatomic Pathology market.
The report discusses in detail the global production capacity, demand and supply ratio, market dynamics, and comprehensive analysis of the competitive landscape. It provides an industry-wide analysis of the market share of each players along with their business portfolio, production and manufacturing capacity, product portfolio, business expansion plans, financial standing, and strategic alliances such as mergers and acquisitions, joint ventures, and collaborations, among others.
Order this report @ https://www.reportsanddata.com/report-pricing/2763
The regional bifurcation of the market analyzes key market segments such as North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. The report discusses in detail the market growth, market size, revenue growth, market share, production and consumption, demand and supply, current and emerging trends, and technological developments in each region.
The key geographical regions analyzed in the market report are:
- North America (U.S.A., Canada)
- Europe (U.K., Italy, Germany, France, Rest of EU)
- AsiaPacific (India, Japan, China, South Korea, Australia, Rest of APAC)
- Latin America (Chile, Brazil, Argentina, Rest of Latin America)
- Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)
Anatomic Pathology Market Segmentation based on Types:
Product and Services Outlook (Revenue in Million USD; 2018–2028)
- Microtomes & Cryostat
- Tissue processors
- Automatic Stainer
- Slide Staining Systems
- Embedded Systems
- Cover slippers
- Forensic pathology
- Probes & Kits
Application Outlook (Revenue in Million USD; 2018–2028)
- Disease Diagnosis
- Drug Discovery and Development
- Medical Research
End-use Outlook (Revenue in Million USD; 2018–2028)
- Hospital Laboratories
- Clinical Laboratories
To know more about the report @ https://www.reportsanddata.com/report-detail/anatomic-pathology-market
Further key findings from the report suggest
- Various companies have entangled into mergers and acquisitions to keep their strong presence in the market. For instance in 2018, Sakura Finetek, which is a U.S. based company, got into a merger with Laboratory Medicine and Henry Ford Health System Pathology.
- The merger is expected to increase the automation level of Sakura Finetek’s pathology laboratories and decrease the errors and to obtain faster accurate results. Such automation increases the workflow and productivity of laboratories.
- Introduction of various new technologies and products in the market is expected to fuel the market growth. For instance, in 2018, Sakura Finetek introduced a manual microtome called as Accu-Cut SRM 300 LT.
- The product is known to be installed with a latest feature which is a 4-color LED backlit 3D precision Chuck. This feature enables the pathologist to check samples tissues embedded in paraffin as well as more simplified and faster visualization of biopsies could be conducted.
Request a customization on the report @ https://www.reportsanddata.com/request-customization-form/2763
Thank you for reading our report. For further inquiry or query about customization, kindly get in touch with us to know more. Our team will clear your doubts and ensure the report is customized to meet your requirements.
Browse More Reports:
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.
Head of Business Development
Reports and Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: [email protected]